Photopatch testing (PPT) represents the gold standard diagnostic evaluation for photoallergic contact dermatitis (PACD), a type IV hypersensitivity reaction to an antigen that occurs in the presence of ultraviolet A radiation. The most common photoallergens in the United States are organic sunscreen filters, whereas topical NSAIDs predominate in Europe. PACD is not rare among photosensitive patients; however, PPT is underperformed in clinical practice due to several limiting factors. Herein, we provide practical approaches to PPT based on expert opinion, including straightforward recommendations on patient selection and testing procedure.
Get full access to this article
View all access options for this article.
References
1.
GuentherJ, JohnsonH, YuJ, et al.Photoallergic contact dermatitis: No fun in the sun. Cutis. 2022;110(5):241–267.
2.
DeLeoVA, AdlerBL, BelsitoDV, et al.Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009–2020. Contact Dermatitis. 2024;91(6):465–473.
3.
CodeçoC, AlvesPB, FigueiredoAC, et al.Shedding a light on the importance of photopatch testing: A 12-year experience in a dermatology unit. Contact Dermatitis. 2023;88(6):438–445.
4.
Gómez-MartínezS, Brufau-CochsM, de la Iglesia-MartínJ, et al.Long-term observations on the European Photopatch Test Baseline Series (EPTBS) in real clinical practice: 11 years of results in a Spanish cohort and suggestions for an EPTBS update. Contact Dermatitis. 2025;92(4):277–282.
5.
AsemotaE, CrawfordG, KovarikC, et al.A survey examining photopatch test and phototest methodologies of contact dermatologists in the United States: Platform for developing a consensus. Dermatitis. 2017;28(4):265–269.
6.
KimT, TaylorJS, MaibachHI, et al.Photopatch testing among members of the American contact dermatitis society. Dermatitis. 2020;31(1):59–67.
7.
LimHW, HawkJLM. Evaluation of the photosensitive patient. In: Photodermatology. (LimHW, HönigsmannH, HawkJLM., eds.) Informa Healthcare USA, Inc.: New York; 2007; pp. 139–148.
8.
WuPA. The importance of education when patch testing. Dermatol Clin. 2020;38(3):351–360.
RalphN, GoossensA, CarrascosaJM, et al.Prospective multi-centre photopatch test study of photoallergy to sunscreens and NSAIDs in Europe. Br J Dermatol.2026:ljag085.
11.
European Multicentre Photopatch Test Study (EMCPPTS) Taskforce. A European multicentre photopatch test study. Br J Dermatol. 2012;166(5):1002–1009.
12.
AdlerBL, HouleMC, PrattM. Photoaggravated contact dermatitis to methylisothiazolinone and associated photosensitivity: A case series. Dermatitis. 2022;33(5):e60–e63.
